Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Transfusion

Retrieve available abstracts of 102 articles:
HTML format



Single Articles


    August 2022
  1. SEHEULT JN, Callum J, Delaney M, Drake R, et al
    Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Transfusion. 2022;62 Suppl 1:S185-S192.
    PubMed     Abstract available


    July 2022
  2. BADE NA, Giri U, Wang H, Ershler WB, et al
    Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center.
    Transfusion. 2022;62:1462-1464.
    PubMed    


  3. FUJA C, Kothary V, Carll TC, Singh S, et al
    Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Transfusion. 2022;62:1446-1451.
    PubMed     Abstract available


  4. HANSEN DL, Moller S, Berentsen S, Frederiksen H, et al
    Mortality in cold agglutinin disease shows seasonal pattern.
    Transfusion. 2022;62:1460-1461.
    PubMed    


    June 2022
  5. KRANENBURG FJ, Arbous SM, Caram-Deelder C, Putter H, et al
    Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16998.
    PubMed     Abstract available


  6. PROCHASKA M, Salcedo J, Berry G, Meltzer D, et al
    Racial differences in red blood cell transfusion in hospitalized patients with anemia.
    Transfusion. 2022 Jun 3. doi: 10.1111/trf.16935.
    PubMed     Abstract available


    May 2022
  7. JOUZIER C, Cherait A, Cony-Makhoul P, Hamel JF, et al
    Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM).
    Transfusion. 2022;62:961-973.
    PubMed     Abstract available


    April 2022
  8. CARLL T, Mei Z, Aldarweesh F, Wool GD, et al
    Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy.
    Transfusion. 2022;62:916-918.
    PubMed    


    March 2022
  9. GUINN NR, Fuller M, Murray S, Aronson S, et al
    Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery.
    Transfusion. 2022 Mar 11. doi: 10.1111/trf.16847.
    PubMed     Abstract available


  10. MEENAN J, Hall R, Badle S, Chatterjee B, et al
    Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Transfusion. 2022;62:546-550.
    PubMed     Abstract available


  11. WADE J, Yee MEM, Easley KA, Pahz S, et al
    Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
    Transfusion. 2022;62:584-593.
    PubMed     Abstract available


  12. YEE ME, Francis RO, Luban NLC, Easley KA, et al
    Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Transfusion. 2022;62:551-555.
    PubMed     Abstract available


  13. SEEBER P, Dobel KU, Isbister JP, Murray K, et al
    Mortality and morbidity in non-transfusable and transfusable patients: A systematic review and meta-analysis.
    Transfusion. 2022;62:685-697.
    PubMed    


    February 2022
  14. SCHIFFER CA
    Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50-54).
    Transfusion. 2022;62:267-272.
    PubMed    


    January 2022
  15. PATRIQUIN CJ, Pavenski K
    O, wind, if winter comes ... will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease.
    Transfusion. 2022;62:2-10.
    PubMed    


  16. ROTH A, Fryzek J, Jiang X, Reichert H, et al
    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Transfusion. 2022;62:51-59.
    PubMed     Abstract available


  17. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    PubMed     Abstract available


  18. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    PubMed     Abstract available


    December 2021
  19. LEE ES, Hendrickson JE, Tormey CA
    RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
    Transfusion. 2021;61:3283-3285.
    PubMed    


  20. KARKI S, Davison TE, Liu B, Bell K, et al
    Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors.
    Transfusion. 2021;61:3335-3343.
    PubMed     Abstract available


  21. ARNONI CP, Vendrame T, Muniz J, Cortez A, et al
    RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.
    Transfusion. 2021;61:3473-3482.
    PubMed     Abstract available


    November 2021
  22. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    PubMed     Abstract available


  23. LIOU S, Bakic L, Manakelew B, Guillermo F, et al
    False anemia due to total parenteral nutrition and lipid emulsion contamination.
    Transfusion. 2021 Nov 5. doi: 10.1111/trf.16728.
    PubMed    


  24. HAMILTON CM, Davenport DL, Bernard AC
    Demonstration of a U.S. nationwide reduction in transfusion in general surgery and a review of published transfusion reduction methodologies.
    Transfusion. 2021;61:3119-3128.
    PubMed     Abstract available


  25. YAMAMOTO T, Bikhet MH, Marques MB, Nguyen HQ, et al
    Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.
    Transfusion. 2021;61:3104-3118.
    PubMed     Abstract available


    October 2021
  26. KAMESAKI T
    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
    Transfusion. 2021 Oct 19. doi: 10.1111/trf.16709.
    PubMed     Abstract available


  27. CALLAN MB, Thawley VJ, Marryott KA, Shabro A, et al
    Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Transfusion. 2021 Oct 11. doi: 10.1111/trf.16690.
    PubMed     Abstract available


  28. TANG CH, Furnback W, Wang BCM, Tang J, et al
    Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Transfusion. 2021;61:2906-2917.
    PubMed     Abstract available


  29. LAL A, Wong T, Keel S, Pagano M, et al
    The transfusion management of beta thalassemia in the United States.
    Transfusion. 2021;61:3027-3039.
    PubMed    


  30. ABEL GA, Klepin HD, Magnavita ES, Jaung T, et al
    Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Transfusion. 2021;61:2830-2836.
    PubMed     Abstract available


    September 2021
  31. GADI SRV, Brunker PAR, Al-Samkari H, Sykes DB, et al
    Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV-2 mRNA Vaccine.
    Transfusion. 2021 Sep 22. doi: 10.1111/trf.16672.
    PubMed     Abstract available


  32. ANG AL, Lim CY, Ng WY, Lam JCM, et al
    Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Transfusion. 2021;61:2566-2577.
    PubMed     Abstract available


  33. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    PubMed     Abstract available


    August 2021
  34. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    PubMed    


  35. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    PubMed     Abstract available


  36. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    PubMed     Abstract available


  37. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    PubMed     Abstract available


  38. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    PubMed     Abstract available


    July 2021
  39. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    PubMed     Abstract available


  40. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.
    PubMed    


  41. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    PubMed     Abstract available


  42. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    PubMed     Abstract available


    June 2021
  43. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    PubMed     Abstract available


  44. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.
    PubMed    


  45. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.
    PubMed    


    May 2021
  46. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    PubMed     Abstract available


  47. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    PubMed     Abstract available


  48. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.
    PubMed    


  49. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.
    PubMed    


    April 2021
  50. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    PubMed     Abstract available


  51. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    PubMed     Abstract available


    March 2021
  52. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    PubMed     Abstract available


  53. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    PubMed     Abstract available


    February 2021
  54. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available


  55. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.
    PubMed    


  56. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    PubMed     Abstract available


  57. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    PubMed     Abstract available


  58. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    PubMed     Abstract available


    January 2021
  59. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    PubMed     Abstract available


  60. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    PubMed     Abstract available


  61. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.
    PubMed    


  62. VASSALLO RR
    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.
    PubMed    


  63. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    PubMed     Abstract available


  64. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    PubMed     Abstract available


  65. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.
    PubMed    


    December 2020
  66. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    PubMed     Abstract available


  67. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    PubMed     Abstract available


    October 2020
  68. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.
    PubMed    


  69. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    PubMed     Abstract available


  70. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available


  71. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    PubMed     Abstract available


  72. FERGUSSON DA, Lalu MM
    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.
    PubMed    


    September 2020
  73. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    PubMed     Abstract available


  74. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available


    August 2020
  75. ERSHLER WB, Holbrook ME
    Sickle Cell Anemia and COVID-19: Use of Voxelotor to Avoid Transfusion.
    Transfusion. 2020 Aug 19. doi: 10.1111/trf.16068.
    PubMed    


  76. BLOCH EM, Branch HA, Sakac D, Leger RM, et al
    Differential red blood cell age fractionation and Band 3 phosphorylation distinguish two different subtypes of warm autoimmune hemolytic anemia.
    Transfusion. 2020 Aug 4. doi: 10.1111/trf.15911.
    PubMed     Abstract available


    July 2020
  77. BIBOULET P, Motais C, Pencole M, Karam O, et al
    Preoperative erythropoietin within a patient blood management program decreases both blood transfusion and postoperative anemia: a prospective observational study.
    Transfusion. 2020 Jul 18. doi: 10.1111/trf.15900.
    PubMed     Abstract available


  78. GUINN NR, Cooter ML, Maisonave Y, Grimsley A, et al
    How do I develop a process to effectively treat parturients with iron deficiency anemia?
    Transfusion. 2020 Jul 13. doi: 10.1111/trf.15930.
    PubMed     Abstract available


  79. YAZDANBAKHSH K, Zhong H
    IVIg and hemolytic anemia risk: dump the anti-A/B already!
    Transfusion. 2020;60:1337-1339.
    PubMed    


    June 2020
  80. JERICO C, Beverina I, Quintana-Diaz M, Salvadori U, et al
    Efficacy and safety of high-dose intravenous iron as the first-choice therapy in outpatients with severe iron deficiency anemia.
    Transfusion. 2020 Jun 29. doi: 10.1111/trf.15870.
    PubMed     Abstract available


  81. WALLENHORST C, Patel A, Shebl A, Hubsch A, et al
    Anti-A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital-based cohort study.
    Transfusion. 2020 Jun 2. doi: 10.1111/trf.15859.
    PubMed     Abstract available


    May 2020
  82. ZUMBERG M, Gorlin J, Griffiths EA, Schwartz G, et al
    A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.
    Transfusion. 2020 May 1. doi: 10.1111/trf.15778.
    PubMed     Abstract available


    April 2020
  83. MAST AE, Langer JC, Guo Y, Bialkowski W, et al
    Genetic and behavioral modification of hemoglobin and iron status among first-time and high-intensity blood donors.
    Transfusion. 2020;60:747-758.
    PubMed     Abstract available


  84. SPENCER BR, Haynes JM, Notari EP 4th, Stramer SL, et al
    Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Transfusion. 2020;60:759-768.
    PubMed     Abstract available


  85. JAIME-PEREZ JC, Garcia-Salas G, Ancer-Rodriguez J, Gomez-Almaguer D, et al
    Audit of red blood cell transfusion in patients with acute leukemia at a tertiary care university hospital.
    Transfusion. 2020;60:724-730.
    PubMed     Abstract available


    March 2020
  86. BLOCH EM, Hull J, Green-Thompson R, Ingram C, et al
    Antenatal blood transfusion in South Africa: indications and practice in a high-HIV-prevalence setting.
    Transfusion. 2020;60:479-487.
    PubMed     Abstract available


  87. LIN DM, Becker J, Wu Y, Cooling L, et al
    How do I perform whole blood exchange?
    Transfusion. 2020;60:449-453.
    PubMed    


    February 2020
  88. HINDAWI S, Badawi M, Elfayoumi R, Elgemmezi T, et al
    The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.
    Transfusion. 2020;60 Suppl 1:S15-S21.
    PubMed     Abstract available


  89. ELSHINAWY M, Kamal M, Nazir H, Khater D, et al
    Sepsis-related anemia in a pediatric intensive care unit: transfusion-associated outcomes.
    Transfusion. 2020;60 Suppl 1:S4-S9.
    PubMed     Abstract available


  90. BLATYTA PF, Kelly S, Sabino E, Preiss L, et al
    Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.
    Transfusion. 2020;60:343-350.
    PubMed     Abstract available


    January 2020
  91. GOLDSTEIN GP, Rao A, Ling AY, Ding VY, et al
    Influence of enteral feeding and anemia on tissue oxygen extraction after red blood cell transfusion in preterm infants.
    Transfusion. 2020 Jan 26. doi: 10.1111/trf.15680.
    PubMed     Abstract available


  92. GUDLAUGSSON B, Hjartardottir H, Svansdottir G, Gudmundsdottir G, et al
    Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Transfusion. 2020;60:175-183.
    PubMed     Abstract available


  93. VAN BUREN NL, Gorlin JB, Corby SM, Cassidy S, et al
    How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Transfusion. 2020;60:16-25.
    PubMed     Abstract available


  94. LEE LE, Beeler BW, Graham BC, Cap AP, et al
    Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab.
    Transfusion. 2020;60:30-35.
    PubMed     Abstract available


    December 2019
  95. JACKSON CHORNENKI NL, James TE, Barty R, Liu Y, et al
    Blood loss from laboratory testing, anemia, and red blood cell transfusion in the intensive care unit: a retrospective study.
    Transfusion. 2019 Dec 28. doi: 10.1111/trf.15649.
    PubMed     Abstract available


  96. COOLING L, Hugan S
    Daratumumab in combination with standard treatment for autoimmune hemolytic anemia in a pediatric patient.
    Transfusion. 2019;59:3801-3802.
    PubMed    


    November 2019
  97. ROEHMEL J, Specht P, Staab D, Schwarz C, et al
    Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
    Transfusion. 2019 Nov 14. doi: 10.1111/trf.15591.
    PubMed     Abstract available


  98. CRISPIN P
    Effect of anemia on muscle oxygen saturation during submaximal exercise.
    Transfusion. 2019 Nov 12. doi: 10.1111/trf.15588.
    PubMed     Abstract available


    October 2019
  99. CRISPIN P, Sliwinski K, Wilson C, Lennard S, et al
    Cold reacting anti-M causing delayed hemolytic disease of the newborn.
    Transfusion. 2019 Oct 31. doi: 10.1111/trf.15578.
    PubMed     Abstract available


  100. WEBB J
    The use of rejuvenated red blood cells for transfusion in patients with sickle cell anemia.
    Transfusion. 2019;59:3042-3045.
    PubMed    


    September 2019
  101. BAHR TM, DuPont TL, Christensen TR, Rees T, et al
    Evaluating emergency-release blood transfusion of newborn infants at the Intermountain Healthcare hospitals.
    Transfusion. 2019 Sep 3. doi: 10.1111/trf.15495.
    PubMed     Abstract available


    March 2019
  102. SHEHATA N, Mazer CD
    Red cell transfusion in cardiac surgery: what is the right balance?
    Transfusion. 2019;59:903-904.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: